Naltrexone (Vivitrol) prior authorization at Point32Health
Submission criteria, P2P prep, and appeal path if denied — for prescribers and PA staff
Point32Health requires prior-authorization documentation for Naltrexone (Vivitrol): a diagnosis with ICD-10 code, documented step-therapy history, and prescriber attestation of medical necessity. Standard PA decisions return in 30 days; if denied, prescribers and members have 180 days to appeal.
The PA criteria you'll need to meet
Point32Health reviews Naltrexone (Vivitrol) prior authorizations against its medical policy . Point32Health-specific context: Formed by 2021 merger of Tufts Health Plan and Harvard Pilgrim Health Care; ~2M members across New England. Brands operate separately (Harvard Pilgrim, Tufts Health Plan). MA DOI primary regulator; MA OPP external review applies in Massachusetts.
Documentation packet checklist
- Chart note with diagnosis (ICD-10 code) and clinical severity markers
- Documented failure of, contraindication to, or intolerance of step-therapy alternatives in this class
- Prior treatment history including dosing, duration, and reason for discontinuation
- Relevant labs, imaging, or assessment scores supporting medical necessity
- Prescriber attestation linking the FDA-approved indication to the patient's presentation
- Point32Health's medical policy URL referenced in the cover letter
Point32Health's common denial patterns
Pre-empting these patterns in the initial submission cuts rework and shortens time-to-approval:
- Harvard Pilgrim vs Tufts Health Plan operational differences (pre-merger legacy)
- MA mandated benefit disputes
- Specialty drug PA
- Behavioral health prior auth
Naltrexone (Vivitrol)-specific denial patterns and context
Across payers (not just Point32Health), Naltrexone (Vivitrol)draws a distinct set of denial reasons rooted in the drug's label, REMS, and competitive landscape:
- Step therapy
- Frequency reduction
Oral and extended-release (Vivitrol) formulations. Used for OUD and AUD.
Manufacturer patient-assistance program: Alkermes Patient Access — relevant when a Point32Health denial sticks and the patient needs bridge access while appealing.
How Point32Health approaches Medications for Opioid Use Disorder (MOUD) PAs
Point32Health's Medications for Opioid Use Disorder (MOUD) reviewer typically anchors Naltrexone prior-auth decisions on specialty drug pa and behavioral health prior auth. Pharmacy-benefit review for Naltrexone at Point32Health is routed through Express Scripts (Harvard Pilgrim and Tufts Health Plan brands). The 30-day standard review window starts when the prior-authorization request is received with all required documentation — incomplete packets pause the clock and add 5-10 days to time-to-approval, after which the 180-day internal-appeal window begins from the denial date. MHPAEA non-quantitative-treatment-limitation analysis applies — request Point32Health's written NQTL comparative analysis under the 2023 final rule when the MOUD denial appears stricter than comparable medical-side prior auth. Point32Health is domiciled in MA, so unresolved appeals escalate to the MA insurance department's external-review program for fully-insured policies (self-funded ERISA plans route to the DOL EBSA instead). Formed by 2021 merger of Tufts Health Plan and Harvard Pilgrim Health Care; ~2M members across New England.
If the PA is denied
Point32Health gives prescribers and members 180 days to file an internal appeal. Standard appeal decisions return within 30 days. Submit through the provider portal (https://www.point32health.org/providers) with the same packet plus a peer-reviewed citation supporting Naltrexone (Vivitrol)for the patient's indication.
Helping a patient appeal the denial directly? See the consumer guide: How to appeal a Point32Health denial on DenialHelp.
Contact Point32Health
- Provider portal: https://www.point32health.org/providers
Frequently asked questions
What documentation does Point32Health need for Naltrexone (Vivitrol) prior auth?
Point32Health's typical PA packet for Naltrexone (Vivitrol): (1) chart note documenting the indication and prior-treatment failures, (2) supporting lab/imaging where indicated, (3) prescriber attestation that step-therapy alternatives were tried or contraindicated, (4) FDA-approved indication mapped to ICD-10 diagnosis.
What's the turnaround time at Point32Health?
Standard Naltrexone (Vivitrol) PA decisions at Point32Health: 30 days. Urgent / expedited (member's life or function at risk): 72 hours under 45 CFR §147.136.
What does Point32Health most often reject Naltrexone (Vivitrol) for?
Across Point32Health's book the common rejection patterns include: Harvard Pilgrim vs Tufts Health Plan operational differences (pre-merger legacy); MA mandated benefit disputes; Specialty drug PA. For Naltrexone (Vivitrol) specifically, expect step-therapy challenges and indication-restriction reviews when the use is at the edge of the FDA label or off-label.
Can Point32Health apply step therapy to MOUD like Naltrexone?
MHPAEA prohibits non-quantitative treatment limitations on MOUD that are stricter than the limits on comparable medical/surgical benefits. Request Point32Health's written NQTL comparative analysis under the 2023 MHPAEA final rule. State Medicaid MCO plans are additionally required to cover all FDA-approved MOUD products without step therapy under the SUPPORT Act (2018) and related state plan amendments. Pharmacy-benefit handling is routed through Express Scripts (Harvard Pilgrim and Tufts Health Plan brands). External-review escalation for Point32Health fully-insured policies sits with the MA insurance department.
How do I prep for a peer-to-peer with Point32Health on Naltrexone (Vivitrol)?
Lead with the FDA-approved indication and the specific clinical criteria the policy lists. Have the patient's chart open, document number, and policy URL on screen. State your name and credentials, the policy number, the indication, and the documented failures of step-therapy alternatives. Keep notes — if the P2P reviewer overturns, get the decision in writing.
Related PA criteria
Generate the Naltrexone (Vivitrol) PA packet
Open ApprovalHelp — generate a Naltrexone (Vivitrol) prior-auth packet tailored to Point32Health's criteria, with prescriber attestation and step-therapy documentation pre-filled.
Get started →Contact: hello@approvalhelp.com